SQZ Biotechnologies (SQZ) News Today → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free SQZ Stock Alerts $0.02 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 8, 2024 | investing.comSqz Bio (SQZB) Earnings Dates & ReportsApril 1, 2024 | bizjournals.comVC funding update: who raised money in March?March 19, 2024 | finance.yahoo.comPortal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VCDecember 28, 2023 | seekingalpha.comSQZB SQZ Biotechnologies CompanyDecember 12, 2023 | morningstar.comSQZ Biotechnologies Co Ordinary Shares SQZBNovember 8, 2023 | finance.yahoo.comSQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio UpdatesNovember 8, 2023 | msn.comSQZ Biotechnologies GAAP EPS of -$0.80 misses by $0.30, revenue of $0MNovember 4, 2023 | morningstar.comLifeline Biotechnologies Inc LLBONovember 3, 2023 | finance.yahoo.comSQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual MeetingAugust 10, 2023 | finance.yahoo.comSQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio UpdatesAugust 3, 2023 | investing.comSqz Biotechnologies Co (SQZB)July 25, 2023 | benzinga.comSQZ Biotechnologies Provides Update on Collaboration with RocheJuly 3, 2023 | seekingalpha.comSQZ Biotechnologies to be delisted from the NYSEJuly 3, 2023 | finance.yahoo.comNYSE to Commence Delisting Proceedings Against SQZ Biotechnologies Company (SQZ)July 3, 2023 | marketbeat.comTrading was temporarily halted for "SQZ" at 01:07 PM with a stated reason of "News pending."June 15, 2023 | finance.yahoo.comSQZ Biotechnologies to Consolidate Shares with 1-for-10 Reverse Stock SplitMay 11, 2023 | markets.businessinsider.comH.C. Wainwright Reaffirms Their Hold Rating on SQZ Biotechnologies (SQZ)May 10, 2023 | finance.yahoo.comSQZ Biotechnologies Reports First Quarter 2023 Financial Results and Recent Portfolio UpdatesMay 10, 2023 | finance.yahoo.comSQZ Biotechnologies Company (SQZ) Reports Q1 Loss, Misses Revenue EstimatesApril 17, 2023 | finance.yahoo.comInvestors Aren't Entirely Convinced By SQZ Biotechnologies Company's (NYSE:SQZ) RevenuesMarch 29, 2023 | msn.comSQZ Biotechnologies's Return On Capital Employed InsightsMarch 24, 2023 | benzinga.comShort Volatility Alert: Sqz BiotechnologiesMarch 24, 2023 | markets.businessinsider.comBTIG Remains a Buy on SQZ Biotechnologies (SQZ)March 23, 2023 | finance.yahoo.comSQZ Biotech's Cancer Candidate Shows Response At Low Dose In HPV16+ Solid Tumor PatientMarch 22, 2023 | marketwatch.comStocks to Watch: Coinbase, Agile Therapeutics, Steelcase, SQZ BiotechnologiesMarch 22, 2023 | marketwatch.comSQZ Biotechnologies Shares Advance 44% on Continued AAC TrialMarch 22, 2023 | markets.businessinsider.comSQZ Biotechnologies Stock Jumps 40% On Confirmed Complete Response HPV16+ Solid Tumor PatientMarch 22, 2023 | finance.yahoo.comSQZ Biotechnologies Reports Full Year 2022 Financial Results and Recent Portfolio UpdatesMarch 22, 2023 | finance.yahoo.comSQZ Biotechnologies Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical TrialJanuary 19, 2023 | msn.comSQZ Biotechnologies gets non-compliance notice from NYSEJanuary 18, 2023 | finance.yahoo.comSQZ Biotechnologies Receives Notice Regarding Continued Listing Standards From the New York Stock ExchangeDecember 16, 2022 | benzinga.comSQZ Biotechnologies's Return On Capital Employed OverviewDecember 6, 2022 | finance.yahoo.comSQZ Biotechnologies Receives FDA Fast Track Designation for its eAPC Therapeutic Candidate for Treatment of HPV16+ Tumors and Presents Clinical Data for Multiple Programs at the European Society for Medical Oncology Immuno-Oncology CongressDecember 1, 2022 | benzinga.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SQZ Biotechnologies Company - SQZDecember 1, 2022 | markets.businessinsider.comAnalyst Ratings for SQZ BiotechnologiesDecember 1, 2022 | markets.businessinsider.comExpert Ratings for SQZ BiotechnologiesDecember 1, 2022 | seekingalpha.comSQZ Biotech CEO steps down amid 60% workforce reduction, pause on some clinical programsDecember 1, 2022 | finance.yahoo.comRoche-partnered cell therapy company lays off most of its staff, loses CEO, CFONovember 30, 2022 | finance.yahoo.comSQZ Biotechnologies Announces Strategic Prioritization of SQZ® Enhanced Antigen Presenting Cells Program; Armon Sharei to Step Down as Chief Executive OfficerNovember 12, 2022 | finance.yahoo.comSQZ Biotechnologies Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues LagNovember 10, 2022 | finance.yahoo.comSQZ Biotechnologies Presents Cell Squeeze® Manufacturing Platform, Linked Antigen mRNA Preclinical Research, and COMMANDER-001 Phase 1/2 Clinical Trial in Progress Poster at Society for Immunotherapy of Cancer Annual MeetingNovember 9, 2022 | finance.yahoo.comSQZ Biotechnologies Reports Third Quarter 2022 Financial Results and Recent Portfolio UpdatesNovember 8, 2022 | finance.yahoo.comMultiple insiders bought SQZ Biotechnologies Company (NYSE:SQZ) stock earlier this year, a positive sign for shareholdersOctober 3, 2022 | benzinga.comSQZ Biotechnologies Publishes Preclinical Research Demonstrating SQZ® AAC Platform's Potential as an Effective Red Blood Cell-Derived ImmunotherapyOctober 3, 2022 | finance.yahoo.comSQZ Biotechnologies Publishes Preclinical Research Demonstrating SQZ® AAC Platform’s Potential as an Effective Red Blood Cell-Derived ImmunotherapySeptember 26, 2022 | nasdaq.comIs SQZ Biotechnologies (NYSE:SQZ) In A Good Position To Invest In Growth?September 12, 2022 | finance.yahoo.comSQZ Biotechnologies Presents Preclinical SQZ® TIL Data Supporting Potential Ability of mRNA-Driven IL-2 and IL-12 Expression to Eliminate Need for Toxic Preconditioning and Systemic IL-2 Administration for Certain T Cell TherapiesSeptember 6, 2022 | finance.yahoo.comSQZ Biotechnologies Announces Leadership TransitionAugust 11, 2022 | finance.yahoo.comWill SQZ Biotechnologies (NYSE:SQZ) Spend Its Cash Wisely?August 4, 2022 | seekingalpha.comSQZ Biotechnologies GAAP EPS of -$0.78 misses by $0.01, revenue of $3.22M misses by $0.97M Get SQZ Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SQZ and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. SQZ Media Mentions By Week SQZ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SQZ News Sentiment▼0.000.48▲Average Medical News Sentiment SQZ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SQZ Articles This Week▼00▲SQZ Articles Average Week Get SQZ Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SQZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACOR News Today SCNI News Today PKBO News Today WINT News Today CMRA News Today BLPH News Today ADTX News Today TIVC News Today BTTX News Today SXTC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:SQZ) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss RatingsUrgent Nvidia WarningAltimetryClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SQZ Biotechnologies Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
